While HARS1 mutations have been implicated in peripheral neuropathy due to impaired protein synthesis and increased cellular stress [33], its downregulation in DN may suggest a similar mechanism within renal tissues. This evidence concerns the gene HARS1 and liver dysplastic nodule.